Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Are Politicians Psychopaths? More Often Than You Might Imagine, Says NY Times Bestselling Expert
  • USA - English


News provided by

Tor/Forge

Oct 15, 2013, 03:00 ET

Share this article

Share toX

Share this article

Share toX


New York, New York (PRWEB) October 15, 2013 -- An AP poll released on October 9th gave Congress a dismal 5% approval rating, and surveys show that many people find politicians to be deplorable. But are they psychopaths? "One percent of the population can be classified as psychopathic," said Douglas E. Richards, a New York Times bestselling author and expert in psychopathy, "and this percentage is likely to be far higher among our political class."

Richards has spoken extensively about the behavior patterns of psychopaths

Post this

Richards has a master's degree in molecular biology, served as Director of Biotechnology Licensing at Bristol-Myers Squibb, and is known for writing meticulously researched thrillers in the tradition of Michael Crichton. The plot of his latest novel, THE CURE, is driven by startling new research showing the brains of psychopaths differ from those of non-psychopaths. Richards’s comprehensive study of psychopathy while writing THE CURE included consultations with a scientist who conducts brain scans on psychopathic murderers and rapists, and he has spoken extensively on the topic, most recently as a guest on Coast to Coast AM with George Noory.

“While few psychopaths are the Hannibal Lecter type, even non-criminal psychopaths leave a trail of shattered lives in their wakes,” explained Richards. “Psychopaths lie, manipulate, bully, and seduce to get what they want, caring nothing for those they trample in the process. They are predators, and we are prey, and they feel as much compassion and empathy for others as wolves feel for sheep.”

In addition to being absolutely selfish—without conscience, empathy, or remorse—psychopaths are cold-blooded, callous, and cool under pressure. But they can also be unbelievably charming and charismatic. They are smooth talkers who are never embarrassed or self-conscious, and make brilliant liars.

While it has been estimated that twenty percent of our prison populations, both male and female, are comprised of psychopaths, many are not criminal. They are the unscrupulous coworker who plays the boss like a fiddle, takes credit for your work, and stabs you in the back with a smile. They are the charmer who moves in with a girlfriend, sucks her dry financially and emotionally, and then spits her out and moves on without a care in the world. One study found psychopaths are three times more prevalent among business executives than in the general population.

While no studies have been done on our political class, Richards believes the prevalence of psychopaths among politicians is far higher than average, although he cautions that only an expert can diagnose this condition for sure, using a tool called the Hare Psychopathy Checklist-Revised. This diagnostic involves a standardized interview and examination of a subject’s history, looking for evidence that the subject is deceitful and manipulative, superficial, narcissistic, unselfconsciousness, unsympathetic, and so on.

“Psychopaths are deceitful, narcissistic backstabbers," said Richards. "They are brilliant and shameless liars and manipulators. When caught in a bald-faced lie, a psychopath doesn’t become embarrassed, just changes gears and spins an even bigger lie to cover it up. If you follow politics at all,” added Richards, “these behaviors are all too familiar.”

ABOUT RICHARDS AND THE CURE:

Douglas E. Richards has been widely praised for his ability to weave action, suspense, and science into riveting novels that brilliantly straddle the thriller and science fiction genres. With THE CURE, Richards has done it again, penning a scientifically accurate novel that, according to #1 New York Times bestselling author, Douglas Preston, "Will keep you turning the pages all night long."

In THE CURE, Erin Palmer has a devastating encounter with a psychopath as a young girl. Now a scientist, she may have found the cure for the psychopathic condition. But to use it she'll have to operate outside of the law and violate her most cherished ethical principles. Soon she is being hunted by unknown players with unknown motivations. And the stakes are nothing less than the future course of human history.

"Richards is a tremendous new talent," added Stephen Coonts, author of seventeen New York Times bestselling thrillers. "THE CURE is an extraordinarily good novel that will keep you riveted . . . and thinking."

THE CURE, a hardcover and eBook published by Macmillan (Forge), is available wherever books are sold. To request a review copy, for more information, or to schedule an interview with the author, please contact Karen Lovell at 646.307.5409 or karen.lovell(at)tor(dot)com.

Karen Lovell, Tor/Forge, +1 646.307.5409, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.